PMC:7161517 / 118-1130 10 Projects
Annnotations
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T3 | 0-12 | SP_7 | denotes | Severe acute |
| T60295 | 0-12 | SP_7 | denotes | Severe acute |
| T4 | 13-24 | SP_7;UBERON:0001004 | denotes | respiratory |
| T90939 | 13-24 | SP_7;UBERON:0001004 | denotes | respiratory |
| T5 | 24-47 | SP_7 | denotes | -syndrome coronavirus-2 |
| T19070 | 24-47 | SP_7 | denotes | -syndrome coronavirus-2 |
| T6 | 49-59 | SP_7 | denotes | SARS-CoV-2 |
| T26357 | 49-59 | SP_7 | denotes | SARS-CoV-2 |
| T7 | 107-138 | PG_10;PR:000003622 | denotes | angiotensin-converting enzyme 2 |
| T3432 | 107-138 | PG_10;PR:000003622 | denotes | angiotensin-converting enzyme 2 |
| T8 | 140-144 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
| T99057 | 140-144 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
| T9 | 156-169 | GO:0065007 | denotes | dysregulation |
| T53282 | 156-169 | GO:0065007 | denotes | dysregulation |
| T10 | 182-190 | SP_10 | denotes | SARS-CoV |
| T31949 | 182-190 | SP_10 | denotes | SARS-CoV |
| T11 | 230-234 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
| T17436 | 230-234 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
| T12 | 235-248 | PR:000036013 | denotes | angiotensin 1 |
| T37458 | 235-248 | PR:000036013 | denotes | angiotensin 1 |
| T13 | 252-256 | PR:000036013 | denotes | Ang1 |
| T46294 | 252-256 | PR:000036013 | denotes | Ang1 |
| T14 | 295-299 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
| T60166 | 295-299 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
| T15 | 358-372 | DG_37;PR:000001118 | denotes | angiotensin II |
| T39187 | 358-372 | DG_37;PR:000001118 | denotes | angiotensin II |
| T16 | 373-381 | PR:000001118 | denotes | receptor |
| T33501 | 373-381 | PR:000001118 | denotes | receptor |
| T17 | 396-406 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
| T28542 | 396-406 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
| T18 | 412-429 | CHEBI:25354;CHEBI:25354 | denotes | mineralocorticoid |
| T14634 | 412-429 | CHEBI:25354;CHEBI:25354 | denotes | mineralocorticoid |
| T19 | 430-450 | CHEBI:48561;CHEBI:48561 | denotes | receptor antagonists |
| T38268 | 430-450 | CHEBI:48561;CHEBI:48561 | denotes | receptor antagonists |
| T20 | 460-464 | PR:000003622;G_3;PG_10 | denotes | ACE2 |
| T7996 | 460-464 | PR:000003622;G_3;PG_10 | denotes | ACE2 |
| T21 | 474-484 | GO:0010467 | denotes | expression |
| T85494 | 474-484 | GO:0010467 | denotes | expression |
| T22 | 537-543 | CHEBI:48561;CHEBI:48561 | denotes | agents |
| T23807 | 537-543 | CHEBI:48561;CHEBI:48561 | denotes | agents |
| T23 | 559-564 | NCBITaxon:10239 | denotes | viral |
| T85043 | 559-564 | NCBITaxon:10239 | denotes | viral |
| T24 | 631-645 | UBERON:0004535 | denotes | cardiovascular |
| T68089 | 631-645 | UBERON:0004535 | denotes | cardiovascular |
| T25 | 722-726 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
| T69502 | 722-726 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
| T26 | 727-731 | PR:000036013 | denotes | Ang1 |
| T7389 | 727-731 | PR:000036013 | denotes | Ang1 |
| T27 | 783-787 | UBERON:0002048 | denotes | lung |
| T3955 | 783-787 | UBERON:0002048 | denotes | lung |
| T28 | 812-820 | SP_10 | denotes | SARS-CoV |
| T22854 | 812-820 | SP_10 | denotes | SARS-CoV |
| T29 | 894-899 | PR:000013883 | denotes | renin |
| T79821 | 894-899 | PR:000013883 | denotes | renin |
| T30 | 919-929 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
| T54661 | 919-929 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
| T31 | 933-943 | SP_7 | denotes | SARS-CoV-2 |
| T15931 | 933-943 | SP_7 | denotes | SARS-CoV-2 |